Clinical Trial Update: Quetiapine Prolong, Escitalopram and Hypothalamic-pituitary-adrenocortical (HPA) Axis Activity in Depressed Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating quetiapine prolonged-release in combination with escitalopram and its effect on HPA axis activity in major depressive disorder has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Escitalopram (escitalopram)
• Quetiapine Prolong (quetiapine)

Snippet

Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Major Depression | Phase 3 | Status: COMPLETED